Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.
- DOI
- 10.1186/s12913-019-4039-8
- Published
- 2019 Mar 28
- Container
- BMC health services research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12913-019-4039-8,
title = {Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.},
author = {Morrell L and Wordsworth S and Schuh A and Middleton MR and Rees S and Barker RW},
year = {2019},
journal = {BMC health services research},
doi = {10.1186/s12913-019-4039-8},
url = {https://doi.org/10.1186/s12913-019-4039-8}
}RIS
TY - JOUR TI - Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals. AU - Morrell L AU - Wordsworth S AU - Schuh A AU - Middleton MR AU - Rees S AU - Barker RW PY - 2019 JO - BMC health services research DO - 10.1186/s12913-019-4039-8 UR - https://doi.org/10.1186/s12913-019-4039-8 ER -
APA
L, M., S, W., A, S., MR, M., S, R., & RW, B. (2019). Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.. BMC health services research. https://doi.org/10.1186/s12913-019-4039-8
Source records
- pubmed · retrieved 2026-09-25T17:51:19.851Z